PHARMACOKINETICS OF N-PROPYLAJMALINE IN RELATION TO POLYMORPHIC SPARTEINE OXIDATION

被引：38

作者：

ZEKORN, C

ACHTERT, G

HAUSLEITER, HJ

MOON, CH

EICHELBAUM, M

机构：

[1] UNIV BONN,MED KLIN,D-5300 BONN,FED REP GER

[2] KALI CHEM AG,SPARTA PHARMA,BIOCHEM ABT,HANNOVER,FED REP GER

来源：

KLINISCHE WOCHENSCHRIFT | 1985年 / 63卷 / 22期

关键词：

D O I：

10.1007/BF01740595

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1180 / 1186

页数：7

共 24 条

[1] ORALLY-ADMINISTERED PRAJMALIUM BITARTRATE IN ACUTE AND CHRONIC VENTRICULAR ARRHYTHMIAS
BUSSMANN, WD
MULLER, E
HANEL, HJ
KALTENBACH, M
[J]. AMERICAN JOURNAL OF CARDIOLOGY, 1978, 41 (03) : 577 - 583
[2] STERIC CONFIGURATION AND POLYMORPHIC OXIDATION OF LIPOPHILIC BETA-ADRENOCEPTOR BLOCKING-AGENTS - INVIVO INVITRO CORRELATIONS
DAYER, P
LEEMANN, T
GUT, J
KRONBACH, T
KUPFER, A
FRANCIS, R
MEYER, UA
[J]. BIOCHEMICAL PHARMACOLOGY, 1985, 34 (03) : 399 - 400
[3] INTERINDIVIDUAL VARIATION OF BETA-ADRENOCEPTOR BLOCKING-DRUGS, PLASMA-CONCENTRATION AND EFFECT - INFLUENCE OF GENETIC STATUS ON BEHAVIOR OF ATENOLOL, BOPINDOLOL AND METOPROLOL
DAYER, P
LEEMANN, T
MARMY, A
ROSENTHALER, J
[J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 28 (02) : 149 - 153
[4] DENGLER HJ, 1977, ARZNEIMITTEL-FORSCH, V27-2, P1836
[5] DEFECTIVE N-OXIDATION OF SPARTEINE IN MAN - NEW PHARMACOGENETIC DEFECT
EICHELBAUM, M
SPANNBRUCKER, N
STEINCKE, B
DENGLER, HJ
[J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 16 (03) : 183 - 187
[6] EICHELBAUM M, 1982, CLIN PHARMACOKINET, V7, P1, DOI 10.2165/00003088-198207010-00001
[7] EICHELBAUM M, 1978, BIOL OXIDATION NITRO, P113
[8] EICHELBAUM M, 1984, FED PROC, V43, P98
[9] FRANCIS RJ, 1983, EUR J CLIN PHARM, V23, P529
[10] HAUSLEITER HJ, 1982, EUR J DRUG METAB PH, V7, P329, DOI 10.1007/BF03189637